Your browser doesn't support javascript.
loading
Risk of New-Onset Long COVID Following Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: A Community-Based Cohort Study.
Bosworth, Matthew L; Shenhuy, Boran; Walker, A Sarah; Nafilyan, Vahé; Alwan, Nisreen A; O'Hara, Margaret E; Ayoubkhani, Daniel.
Affiliation
  • Bosworth ML; Data and Analysis for Social Care and Health Division, Office for National Statistics, Newport, United Kingdom.
  • Shenhuy B; Methodology and Quality Directorate, Office for National Statistics, Newport, United Kingdom.
  • Walker AS; National Institute for Health Research Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, United Kingdom.
  • Nafilyan V; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Alwan NA; Data and Analysis for Social Care and Health Division, Office for National Statistics, Newport, United Kingdom.
  • O'Hara ME; Faculty of Public Health, Environment and Society, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Ayoubkhani D; School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Open Forum Infect Dis ; 10(11): ofad493, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37953820
ABSTRACT

Background:

Little is known about the risk of long COVID following reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We estimated the likelihood of new-onset, self-reported long COVID after a second SARS-CoV-2 infection, compared to a first infection.

Methods:

We included UK COVID-19 Infection Survey participants who tested positive for SARS-CoV-2 between 1 November 2021 and 8 October 2022. The primary outcome was self-reported long COVID 12-20 weeks after each infection. Separate analyses were performed for those <16 years and ≥16 years. We estimated adjusted odds ratios (aORs) for new-onset long COVID using logistic regression, comparing second to first infections, controlling for sociodemographic characteristics and calendar date of infection, plus vaccination status in participants ≥16 years of age.

Results:

Overall, long COVID was reported by those ≥16 years after 4.0% and 2.4% of first and second infections, respectively; the corresponding estimates among those aged <16 years were 1.0% and 0.6%. The aOR for long COVID after second compared to first infections was 0.72 (95% confidence interval [CI], .63-.81) for those ≥16 years and 0.93 (95% CI, .57-1.53) for those <16 years.

Conclusions:

The risk of new-onset long COVID after a second SARS-CoV-2 infection is lower than that after a first infection for persons aged ≥16 years, though there is no evidence of a difference in risk for those <16 years. However, there remains some risk of new-onset long COVID after a second infection, with around 1 in 40 of those aged ≥16 years and 1 in 165 of those <16 years reporting long COVID after a second infection.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country: